- POSITIVE
Annual Revenue Hemant Surgical Mar-2026 Annual Revenue is Rs 237 Cr which is growth of 112.0% YoY.
- POSITIVE
Annual Net Profit Hemant Surgical Mar-2026 Annual Net Profit is Rs 18 Cr which is growth of 124.2% YoY.
Hemant Surgical Industries was established on March 27, 1989. The company specializes in manufacturing, importing, assembling, and marketing a diverse range of medical equipment and disposables. Its product portfolio includes a wide range of equipment and disposables essential for renal care, cardiovascular disease, respiratory disease, critical care, radiology, and surgical procedures.
| Bidding Dates |
|---|
| 24 May 2023 - 26 May 2023 |
| Subscription |
|---|
| 139.7x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹144,000 | 1 | 1 | 1600 | 2.8 M | ₹85 - ₹90 | 73.56 % | ₹234.6 M - ₹248.4 M | RHP DOC |
Hemant Surgical IPO SUBSCRIPTION STATUS
26 May '23Total139.7x
Retail Individual Investor158.73x
HNI (NII) Investors203.26x
Qualified Institutional Buyers41.05x
Hemant Surgical IPO overall subscription rate was 139.7 times the total available shares
Hemant Surgical IPO retail subscription rate was 158.73 times in the retail segment
Hemant Surgical IPO non-institutional investor subscription rate was 203.26 times in the non-institutional investor category
Hemant Surgical IPO Qualified Institutional Bidder subscription rate was 41.05 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
26 May 2023 (Day 3) | 158.73x | 203.26x | 41.05x |
25 May 2023 (Day 2) | 46.13x | 20.52x | 2.29x |
24 May 2023 (Day 1) | 4.9x | 1.14x | 0x |
Hemant Surgical FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) |
| FY23 | 76.5 | 1,091.5 | 86.4 | 61.9 |
| FY22 | 46.1 | 1,035.7 | 120.6 | 116.4 |
| FY21 | 11.5 | 597.6 | -2.7 | -26.6 |
Hemant Surgical IPO SUBSCRIPTION STATUS DETAILS
Hemant Surgical had 2.8 M shares on offer
Hemant Surgical IPO offer price was in the range ₹85 - ₹90
Hemant Surgical IPO minimum Investment was ₹144000
Hemant Surgical IPO issue size was ₹ 234.6 M - ₹ 248.4 M
Hemant Surgical had a minimum lot size of 1600 Shares per application
Hemant Surgical NUMBER OF SHARES ON OFFER
Total2.8 M
Fresh Issue2.8 M
Offer for Sale0
Post Issue Promoter Holding %73.56 %
Hemant Surgical IPO IMPORTANT DATES
| Issue Open Date | 24 May 2023 |
| Issue close Date | 26 May 2023 |
| Allotment Date | 31 May 2023 |
| Refund Date | 01 Jun 2023 |
| Demat Account Credit Date | 02 Jun 2023 |
| Listing Date | 05 Jun 2023 |
| Listing on Exchange(s) | BSE |
| Hemant Surgical Allotment Status | Exchange |
Hemant Surgical IPO subscription opened on 24 May 2023, and closed on 26 May 2023
IPO allotment for Hemant Surgical was finalized on Wednesday, 31 May 2023
IPO listing for Hemant Surgical was on BSE on Monday, 05 Jun 2023
Hemant Surgical IPO LISTING GAINS
| Issue Price (adjusted) | 90.0 |
| Listing Open Price | 171.0 |
| Listing Close Price | 179.6 |
| Listing Gain% | 90.0% |
| Current Gain% | 537.3% |
Hemant Surgical Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hemant Surgical Industries Ltd. | 573.6 | 598.8 | 41.1 | 0.5 | 2.5 | 13.2 | 6.6 | 237.7 | 112.7 | 18.2 | 126.2 | 14 | 81.1 |
| Tarsons Products Ltd. | 291 | 1548.3 | 139.5 | -2.3 | 3.5 | 2.2 | 1.2 | 446.7 | 9.4 | 14.3 | -51.9 | 2.1 | -59.7 |
| Fabtech Cleanrooms Ltd. | 445 | 548.2 | 34.7 | 15.2 | 8.5 | 221.7 | 46.9 | 15.8 | 19 | 12.8 | |||
| Prevest Denpro Ltd. | 376.4 | 451.7 | 22 | 1.5 | 6 | 16.4 | 15.4 | 76.7 | 14.4 | 20.5 | 12.9 | 17.1 | 15 |
| QMS Medical Allied Services Ltd. | 181.2 | 350.3 | 29.4 | -0.4 | 1.9 | 11.4 | 5.6 | 173.9 | 10.3 | 11.9 | -1.5 | 6.2 | -69.2 |
| Aprameya Engineering Ltd. | 102 | 194.3 | 38.1 | 7.4 | 6.2 | 55.6 | -59.2 | 5.1 | -68.3 | 2.7 |
Annual
Balance Sheet
Ratios
Cash Flow
Hemant Surgical annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
28.5% | 31.3% | 236.7 | 111.6 | 109.9 | 111.5 | 105.8 | 60.7 | 56.5 | 56.2 | 50.8 | 51.7 | 39.9 | ||
Operating Exp. Ann. | 28.1% | 29.6% | 207.6 | 97.5 | 95.1 | 98.7 | 97.3 | 56.7 | 53.5 | 53 | 48.1 | 49.1 | 37.3 | |
Operating Profit Ann. | 30.6% | 49.8% | 23.4 | 9.1 | 10.5 | 10.5 | 6.3 | 3.1 | 2.6 | 2.7 | 2.5 | 2.4 | 2.3 | |
OPM Ann. % | 1.7% | 14.3% | 9.88% | 8.13% | 9.53% | 9.39% | 5.96% | 5.07% | 4.57% | 4.77% | 4.88% | 4.70% | 5.83% | |
28.1% | 29.2% | 213.1 | 101.1 | 97.1 | 101.4 | 99.7 | 59.1 | 55.6 | 54.9 | 49.8 | 50.9 | 39.2 | ||
EBITDA Ann. | 31.5% | 48.7% | 29.1 | 14.2 | 14.8 | 12.8 | 8.5 | 4 | 3 | 3.2 | 2.8 | 2.7 | 2.6 | |
EBITDA Ann. margin % | 2.3% | 13.5% | 12.30% | 12.71% | 13.45% | 11.50% | 8.04% | 6.53% | 5.33% | 5.64% | 5.43% | 5.16% | 6.41% | |
Interest Ann. | 28.2% | 17.3% | 4 | 2.2 | 1 | 1.9 | 1.6 | 1.8 | 1.4 | 1.4 | 1.3 | 1.6 | 1.7 | |
Depr. | 18.6% | 20.1% | 1.5 | 1.4 | 1 | 0.9 | 0.8 | 0.6 | 0.6 | 0.5 | 0.4 | 0.3 | 0.2 | |
PBT Ann. | 32.7% | 73.5% | 23.6 | 10.6 | 12.8 | 10.1 | 6.1 | 1.5 | 1 | 1.2 | 1 | 0.9 | 0.7 | |
Tax Ann. | 31% | 68.3% | 5.4 | 2.4 | 3 | 2.4 | 1.5 | 0.4 | 0.1 | 0.1 | 0.1 | 0.1 | 0 | |
33.2% | 72.3% | 18.2 | 8.1 | 9.8 | 7.7 | 4.6 | 1.2 | 0.9 | 1.1 | 0.9 | 0.8 | 0.6 | ||
Net Profit Ann. | 33.2% | 72.3% | 18.2 | 8.1 | 9.8 | 7.7 | 4.6 | 1.2 | 0.9 | 1.1 | 0.9 | 0.8 | 0.6 | |
NPM Ann. % | 4.1% | 32.8% | 7.89% | 7.63% | 9.27% | 7.00% | 4.45% | 1.91% | 1.52% | 2.03% | 1.85% | 1.55% | 1.57% | |
EPS Adj. latest Ann. | 33.4% | 73.1% | 14 | 6.2 | 7.5 | 5.9 | 3.5 | 0.9 | 0.7 | 0.9 | 0.7 | 0.6 | 0.5 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
112.1%
2Y CAGR
46.8%
3Y CAGR
28.5%
5Y CAGR
31.3%
7Y CAGR
22.8%
10Y CAGR
19.5%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
1Y CHG
124.7%
2Y CAGR
36.3%
3Y CAGR
33.2%
5Y CAGR
72.3%
7Y CAGR
49.3%
10Y CAGR
40.7%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
112.9%
2Y CAGR
47.7%
3Y CAGR
28.1%
5Y CAGR
29.6%
7Y CAGR
21.5%
10Y CAGR
18.7%
Operating Expenses Annual Cr growth is higher than historical averages.
Hemant Surgical INFORMATION ON IPO ISSUE
About Hemant Surgical
Hemant Surgical Industries was established on March 27, 1989. The company specializes in manufacturing, importing, assembling, and marketing a diverse range of medical equipment and disposables. Its product portfolio includes a wide range of equipment and disposables essential for renal care, cardiovascular disease, respiratory disease, critical care, radiology, and surgical procedures.
Object of the Issue
- Funding capital expenditure towards the installation of additional plant and machinery
- Funding to meet working capital requirements
- General corporate purpose
- Issue expenses
Hemant Surgical - PROMOTERS
| Name |
|---|
| Hanskumar Shamji Shah |
| Hanskumar Shamji Shah |
| Hemant Praful Shah |
Hemant Surgical Lead Manager of the Issue
Hem Securities Limited
ib@hemsecurities.com
Hemant Surgical Registrar to the issue
Bigshare Services Private Limited
ipo@bigshareonline.com
Hemant Surgical Strengths
Diversified products
The company offers a diverse range of medical equipment and disposables, catering to various healthcare needs including renal care solutions, cardiovascular disease, respiratory disease, critical care, radiology, and surgical disposables
Strength
Quality assurance
The company has obtained ISO 9001:2015 and ISO 13485:2016 certifications for quality management systems from AQC Middle East FZE and BSCIC Certifications Pvt. Ltd. respectively
Strength
Stable financial performance
The company has consistently shown stable financial performance, with particularly strong results in the last three fiscal years, including improved margins
Strength
Hemant Surgical Risks
Dependent on one product
The company relies heavily on the sale of one of its products, namely Meditapes imported from JMS. Any failure to anticipate or adapt to changing market trends, ensure product quality, or a decrease in demand for such products could have a negative impact on the company's revenue
Risk
Certain legal proceedings
The company and its directors are currently engaged in legal proceedings and potential litigations. Any unfavourable outcomes in these proceedings could result in liabilities, penalties, or prosecutions, which may have a negative impact on the company's business
Risk
IPO FAQs
The promoters of the company are Hanskumar Shamji Shah, Hanskumar Shamji Shah and Hemant Praful Shah.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 85.0 - 90.0.
The IPO application opens on May 24, 2023 and closes on May 26, 2023.
The minimum lot size for the IPO is 1600. The maximum lot size for the IPO is 1600.
For all category investors, the minimum application amount for this IPO is Rs. 144,000.0, the maximum value for this IPO is Rs 144,000.0.
This IPO will be allotted on May 31, 2023.
The refund will be credited to your account on Jun 01, 2023.
The allotted shares will be credited to your demat on Jun 02, 2023.
Hemant Surgical Industries Ltd.’s shares listed on the stock exchanges on Jun 05, 2023.